Health in Spain 1,087 indicators covering health for Spain. IndicatorLatest Year10-yr change Rank Reported rabies deaths 0 2023 — 61st Number of current cigarette smokers, estimate 8.52 million 2030 down 11.6% 20th Concentrations of fine particulate matter 8.54 2023 down 24.0% 161st Death rate road traffic injuries 3.9 2019 down 27.8% 166th New or unknown treatment history cases: Pulmonary, bacteriologically c 1,550 2022 down 50.7% 97th Cholera case fatality rate 0 2015 — 37th Medical doctors not further defined 27,482 2023 down 12.0% 29th Life satisfaction vs life expectancy 83.67 2023 up 1.2% 13th Estimate of current cigarette smoking prevalence 20.3% 2030 down 14.3% 42nd Estimate of current cigarette smoking prevalence (%) 24.3% 2030 down 8.3% 30th Tb patients tested positive for hiv 233 2014 down 29.0% 69th Number of children aged 6-59 months with anaemia 293.72 2019 down 5.2% 83rd Prevalence of anaemia in children aged 6-59 months 14.6% 2019 up 17.7% 169th Number of deaths attributed to non-communicable diseases, by type of d 109,727 2019 up 3.1% 17th Hepatitis B surface antigen (HBsAg) prevalence 0.0% 2024 — 132nd Mean hemoglobin level of children aged 6-59 months 121 2019 down 0.8% 12th Estimated number of MDR/RR-TB incident cases 63 2024 down 75.8% 106th Mortality caused by road traffic injury 3.9 per 100,000 population 2019 down 35.0% 167th Mortality caused by road traffic injury, female 1.8 per 100,000 female population 2019 down 30.8% 168th Mortality caused by road traffic injury, male 6.1 per 100,000 male population 2019 down 35.8% 165th Ipv vaccine coverage 98 2024 down 1.0% 33rd Hospital beds 29.07 2023 down 1.4% 63rd Treatment success rate for patients treated for MDR-TB 71.0% 2022 up 73.2% 91st New leprosy case detection rate per 1 000 000 population 0.167 2024 down 3.5% 112th Treatment success rate: HIV-positive TB cases 64 2023 up 10.3% 110th Peri-neonatal mortality by age of mother and parity, by NUTS 2 region 926 2023 down 37.0% 7th Fetal, peri- and neonatal mortality rates by NUTS 2 region of occurren 1.86 2023 down 42.9% 26th Bladder cancer death rate 3.16 2023 down 30.5% 21st Cancer death rates by type who db 3.16 2023 down 30.5% 21st Earthquake deaths 10 2011 up 400.0% 14th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) i 98.0% 2025 — 16th International Health Regulations core capacity scores, SPAR version, 2 50 2025 — 85th Leprosy registered prevalence rate per 1 000 000 population 0.167 2024 down 29.5% 109th Leprosy - Number of new leprosy cases among children 0 2024 down 100.0% 69th Leprosy - Number of cases registered for treatment 8 2024 down 27.3% 84th New leprosy child case detection rate (less than 15 years of age) per 0 2024 down 100.0% 69th Hospital discharges by diagnosis and NUTS 2 region, day cases, total n 4.72 million 2021 up 26.3% 3rd Hospital discharges by diagnosis and NUTS 2 region, day cases, total n 2.47 million 2021 up 25.7% 3rd Hospital discharges by diagnosis and NUTS 2 region, day cases, total n 2.25 million 2021 up 27.0% 3rd Hospital days of in-patients by NUTS 2 region - females - historical d 17.62 million 2021 up 13.9% 7th Ipv1 number unvaccinated 10,284 2023 up 142.0% 91st Hospital days of in-patients by NUTS 2 region - males - historical dat 19.95 million 2021 up 23.5% 7th Hospital days of in-patients by NUTS 2 region - total - historical dat 37.57 million 2021 up 18.8% 7th Hospital discharges by diagnosis and NUTS 2 region, in-patients, total 4.51 million 2021 down 4.9% 7th Hospital discharges by diagnosis, NUTS 2 region, in-patients and total 2.33 million 2021 down 6.7% 7th Hospital discharges by diagnosis and NUTS 2 region, in-patients, total 2.18 million 2021 down 2.9% 7th Contraceptive prevalence, any method 62.1% 2018 down 11.4% 44th Hospital discharges by diagnosis and NUTS 2 region, day cases, per 100 9,962 2021 up 23.7% 6th Hospital discharges by diagnosis and NUTS 2 region, day cases, per 100 10,227 2021 up 22.8% 6th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Hospital discharges by diagnosis and NUTS 2 region, day cases, per 100 9,687 2021 up 24.7% 6th Liver cancer death rate 4.57 2023 down 15.6% 44th Hospital discharges by diagnosis and NUTS 2 region, in-patients, per 1 9,519 2021 down 6.8% 22nd Hospital discharges by diagnosis and NUTS 2 region, in-patients, per 1 9,647 2021 down 8.9% 22nd Hospital discharges by diagnosis and NUTS 2 region, in-patients, per 1 9,386 2021 down 4.6% 21st Number of female leprosy new cases 2 2024 down 33.3% 83rd National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 unchanged 1st Contraceptive prevalence, any modern method 59.9% 2018 down 12.3% 27th Number of prevalent tuberculosis cases 6,800 2014 down 32.0% 92nd Public health expenditure share gdp 6.54 2025 up 1.4% 22nd ← Previous Page 15 of 19 Next →